Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-03

Clinical Trial Update: ActiPatch Plantar Fasciitis Clinical Trial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of ActiPatch for plantar fasciitis and plantar fasciopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ActiPatch

Snippet

Sponsor: University of British Columbia | Conditions: Plantar Fasciitis, Plantar Fasciopathy | Phase 3 | Status: COMPLETED